Phenotyping the human tumor-immune microenvironment (TiME) in vivo by cellular-level optical imaging reveals unique combination phenotypes with variable inflammation and endothelial anergy
Shuaitong Li,M. Rajadhyaksha,Teguru Tembo,A. Halpern,A. Alfonso,N. Kurtansky,C. Fox,Aditi Sahu,L. Deng,C. Chen,Pratik Chandrani,S. Yin,C. Navarrete-Dechent,A. Santella,Melissa,Haaris Jilani,A. Marghoob,S. González,N. Yang,M. Cordova,W. Phillips,Pulitzer,K. Kose,S. Dusza,P. Mehta,M. Gill,A. Rossi,Kimeil King,G. Peterson,Madison Li,Piyush Kumar,Amber W. Wang
Abstract:: Immunotherapies, especially immune checkpoint blockade therapy have shown unprecedented clinical benefits in several malignancies, however, responses are variable emphasizing the need for effective biomarkers for patient stratification 1 . Phenotyping of tumors into hot, altered, or cold 2 based on T-lymphocyte infiltration in tumor biopsies fails to explain and/or predict response to immunotherapy seen in a subset of patients 3,4 . One of the primary reasons for this suboptimal prediction by a single immune marker could be attributed to the fact that additional mechanisms within the tumor microenvironment modulate anti-tumor immunity and outcomes, including dynamic events such as tumor-angiogenesis and leukocyte trafficking 2,5,6 . We report novel tumor phenotypes through non-invasive spatially-resolved cellular-level analysis of the tumor immune microenvironment (TiME) and major determinants of anti-tumor immunity. Using skin cancers as a model and optical imaging using reflectance confocal microscopy (RCM) 7 , we determined four major phenotypes based on unsupervised clustering for relative prevalence of vasculature (Vasc) and inflammation (Inf) features: Vasc high Inf high , Vasc high Inf low , Vasc low Inf(intratumoral) high and Vasc mod Inf low . The Vasc high Inf high phenotype correlate with high immune and vascular signatures while Vasc high Inf low with endothelial anergy. Automated quantification of TiME features demonstrates moderate accuracy and high correlation with corresponding gene expression. Prospective testing of TiME features prior to topical immunotherapy response shows highest response in the Vasc low Inf(IT) high phenotype, and revealing the added value of vascular features in predicting treatment response. This novel in vivo phenotyping combining dynamic immune and vascular features has the potential to advance fundamental understanding of the highly dynamic TiME, identify novel druggable pathways and develop robust predictors for immunotherapy outcomes. Towards addressing the dynamic, complex and highly interdependent vascular-inflammation axis inside the TiME, in vivo phenotyping based on a combination of dynamic vascular and immune features, rather than ex vivo phenotyping based on static pathological evaluation of tumor infiltrating cells may facilitate a deeper understanding and achieve higher predictive power for patient stratification for immunotherapies. High-resolution non-invasive in vivo imaging is fundamental to this combination phenotyping, since static ex vivo analyses on patient tissue are limited in recapitulating dynamic vascular and immune attributes 19 . We report novel combination phenotypes detected in vivo using reflectance confocal microscopic (RCM) imaging. RCM is a high-speed (pixel times ~ 0.10 µsec, frame rates 10-30 per second) cellular-level label-free imaging approach based on backscattered light and endogenous tissue contrast 7,20 . Large image mosaics (64 mm 2 in 50 seconds) imaged to a depth of ~0.25 mm enables spatial resolution of TiME features. RCM is routinely used for real-time skin cancer diagnosis and management at the bedside. Few studies have demonstrated RCM imaging of vessels and leukocyte trafficking in humans 21,22 . Using skin cancer as a model, we define novel combination TiME phenotypes using six features: vessel diameter, vessel density, leukocyte trafficking, intratumoral inflammation, peritumoral inflammation and perivascular inflammation (Fig S1) and report their subsequent molecular correlation with inflammatory, angiogenic and trafficking signatures. We also and, in a prospective pilot study, examine their investigated relative importance of TiME features in predicting response to topical immunotherapy. TLS-negative (p<0.001) anti-tumor I. Higher TLS coverage (>0.1 mm2) correlated with higher TILs (p<0.001); Higher TLS area coverage was associated with a statistically higher probability of tumor killing.
Medicine